Showing results (71-80 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|February 3, 2007
High-dose vitamin B6 decreases homocysteine serum levels in patients with schizophrenia and schizoaffective disorders: a preliminary studyChanoch Miodownik, Vladimir Lerner, Tali Vishne, et al.Clinical Neuropharmacology|February 3, 2007
The deployment of intersensory selective attention: a high-density electrical mapping study of the effects of theanineManuel Gomez-Ramirez, Beth A Higgins, Jane A Rycroft, et al.Clinical Neuropharmacology|February 3, 2007
Two years' follow-up of rivastigmine treatment in Huntington diseaseMarina de Tommaso, Olimpia Difruscolo, Vittorio Sciruicchio, et al.Clinical Neuropharmacology|April 7, 2007
Pramipexole in levodopa-treated Parkinson disease patients of African, Asian, and Hispanic heritageClinical Neuropharmacology|April 7, 2007
Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteinsKai Wohlfarth, Christian Müller, Irena Sassin, et al.Clinical Neuropharmacology|April 7, 2007
Acute levodopa intake and associated cortisol decrease in patients with Parkinson diseaseThomas Müller, Siegfried MuhlackClinical Neuropharmacology|January 1, 1991
Side effects during long-term treatment with depot antipsychotic medicationJ C CooksonClinical Neuropharmacology|June 15, 2006
Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case reportQing Rong Tan, Wen Wang, Huai Hai Wang, et al.Clinical Neuropharmacology|June 1, 1988
Lisuride in Parkinson's disease. 4-year follow-upP Giovannini, G Scigliano, I Piccolo, et al.Clinical Neuropharmacology|September 13, 2021
Ischemic Stroke and Provoked Seizure as a Manifestation of Brugmansia suaveolens (Angel's Trumpet) Acute Intoxication: A Detailed Clinical, Electroencephalogram, and Magnetic Resonance Imaging Description and 5-Month Follow-upEleonora Colosimo, Alessandra Clodomiro, Domenico Pirritano, et al.Pageof 236